As of March 2025 Supernus Pharmaceuticals has a market cap of A$2.91 Billion. This makes Supernus Pharmaceuticals the world's 4394th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$2.91 B | -11.56% |
2024 | A$3.30 B | 42.23% |
2023 | A$2.32 B | -18.1% |
2022 | A$2.83 B | 32.47% |
2021 | A$2.13 B | 23.65% |
2020 | A$1.72 B | -2.8% |
2019 | A$1.77 B | -27.86% |
2018 | A$2.46 B | -5.72% |
2017 | A$2.61 B | 50.79% |
2016 | A$1.73 B | 91.94% |
2015 | A$0.90 B | 107.44% |
2014 | A$0.43 B | 28.95% |
2013 | A$0.33 B | 59.97% |
2012 | A$0.21 B |
On Mar 25th, 2025 the market cap of Supernus Pharmaceuticals was reported to be: